Cargando…

Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells

Understanding early events of HIV transmission within mucosal tissues is vital for developing effective prevention strategies. Here, we report that primary stromal fibroblasts isolated from endometrium, cervix, foreskin, male urethra, and intestines significantly increase HIV infection of CD4+ T cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Neidleman, Jason A., Chen, Joseph C., Kohgadai, Nargis, Müller, Janis A., Laustsen, Anders, Thavachelvam, Karthiga, Jang, Karen S., Stürzel, Christina M., Jones, Jennifer J., Ochsenbauer, Christina, Chitre, Avantika, Somsouk, Ma, Garcia, Maurice M., Smith, James F., Greenblatt, Ruth M., Münch, Jan, Jakobsen, Martin R., Giudice, Linda C., Greene, Warner C., Roan, Nadia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312882/
https://www.ncbi.nlm.nih.gov/pubmed/28207890
http://dx.doi.org/10.1371/journal.ppat.1006163
Descripción
Sumario:Understanding early events of HIV transmission within mucosal tissues is vital for developing effective prevention strategies. Here, we report that primary stromal fibroblasts isolated from endometrium, cervix, foreskin, male urethra, and intestines significantly increase HIV infection of CD4+ T cells–by up to 37-fold for R5-tropic HIV and 100-fold for X4-tropic HIV–without themselves becoming infected. Fibroblasts were more efficient than dendritic cells at trans-infection and mediate this response in the absence of the DC-SIGN and Siglec-1 receptors. In comparison, mucosal epithelial cells secrete antivirals and inhibit HIV infection. These data suggest that breaches in the epithelium allow external or luminal HIV to escape an antiviral environment to access the infection-favorable environment of the stromal fibroblasts, and suggest that resident fibroblasts have a central, but previously unrecognized, role in HIV acquisition at mucosal sites. Inhibiting fibroblast-mediated enhancement of HIV infection should be considered as a novel prevention strategy.